Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Sigdase -P Diclofenac Potassium and Paracetamol Tablets
Sigdase -P, offered by Lexaro Healthcare, combines Diclofenac Potassium and Paracetamol in tablet form. Each tablet is meticulously formulated with a focus on quality and efficacy.
Uses of Sigdase -P Diclofenac Potassium and Paracetamol Tablets
Sigdase -P is indicated for the relief of pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and musculoskeletal disorders. It provides effective symptomatic relief, reducing pain and swelling.
Benefits of Sigdase -P Diclofenac Potassium and Paracetamol Tablets
Dual-action formulation combining the anti-inflammatory properties of Diclofenac Potassium with the analgesic effects of Paracetamol.
Rapid onset of action to alleviate acute pain and inflammation.
Improves mobility and enhances quality of life for patients with joint and muscle-related disorders.
Well-tolerated with a favorable safety profile when used as directed.
Mechanism of Action of Sigdase -P Diclofenac Potassium and Paracetamol Tablets
Diclofenac Potassium inhibits the enzyme cyclooxygenase (COX), reducing the synthesis of prostaglandins involved in inflammation and pain. Paracetamol acts centrally to inhibit prostaglandin synthesis in the central nervous system, further enhancing pain relief and reducing fever.